Top Section/Ad
Top Section/Ad
Most recent
Qualifying shareholders take up 68% as remainder stays with conditional placees
Underwriting left unused after deal is 33% oversubscribed
Shareholder-backed recapitalisation will help reduce debt and prepare assets for sale or listing
Placing and open offer follows recent acquisition of US annuity provider
More articles/Ad
More articles/Ad
More articles
-
A lacklustre year for equity capital markets suddenly grew more interesting on Monday, when Bayer announced the details of a $62bn bid for Monsanto. It got still more interesting on Tuesday, when the US agribusiness group rejected the offer as “incomplete and financially inadequate”.
-
Indonesia’s Bank Permata is planning to raise Rph5.5tr ($403.4m) from a rights issue next month, having received the go ahead from the country’s financial regulator, according to a press release from the firm. -
Monsanto has rejected Bayer’s all-cash bid of a $62bn enterprise value as “incomplete and financially inadequate”, but left the door open to an improved offer.
-
Indonesia’s Medco Energi Internasional is planning a rights issue to raise Rph4.66tr ($349.59m), in a deal that could increase its share base by almost half, according to a company filing.
-
Jefferies has hired Vikas Khattar from HSBC as its head of capital markets for India and southeast Asia.
-
Bayer could be preparing to issue one of the five biggest rights issues ever, and the largest by a non-bank company, as part of the financing for its $62bn bid for Monsanto, the US agricultural chemicals and bio-engineering business.
